Show simple item record

dc.contributor.authorKouijzer, IJE
dc.contributor.authorBlokhuis, GJ
dc.contributor.authorDraaisma, JMT
dc.contributor.authorOyen, WJG
dc.contributor.authorde Geus-Oei, L-F
dc.contributor.authorBleeker-Rovers, CP
dc.date.accessioned2016-12-19T14:57:29Z
dc.date.issued2016-04
dc.identifier.citationClinical nuclear medicine, 2016, 41 (4), pp. 278 - 281
dc.identifier.issn0363-9762
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/338
dc.identifier.eissn1536-0229
dc.identifier.doi10.1097/rlu.0000000000001119
dc.description.abstractPurpose of the report Metastatic infection is a severe complication of bacteremia with high morbidity and mortality. The aim of this study was to investigate the diagnostic value of 18F-FDG PET combined with CT (FDG PET/CT) in children suspected of having metastatic infection.Methods The results of FDG PET/CT scans performed in children because of suspected metastatic infection from September 2003 to June 2013 were analyzed retrospectively. The results were compared with the final clinical diagnosis.Results FDG PET/CT was performed in 13 children with suspected metastatic infection. Of the total number of FDG PET/CT scans, 38% were clinically helpful. Positive predictive value of FDG PET/CT was 71%, and negative predictive value was 100%.Conclusions FDG PET/CT appears to be a valuable diagnostic technique in children with suspected metastatic infection. Prospective studies of FDG PET/CT as part of a structured diagnostic protocol are needed to assess the exact additional diagnostic value.
dc.formatPrint
dc.format.extent278 - 281
dc.languageeng
dc.language.isoeng
dc.subjectHumans
dc.subjectBacteremia
dc.subjectFluorodeoxyglucose F18
dc.subjectRadiopharmaceuticals
dc.subjectPositron-Emission Tomography
dc.subjectTomography, X-Ray Computed
dc.subjectAdolescent
dc.subjectChild
dc.subjectInfant
dc.subjectFemale
dc.subjectMale
dc.subjectMultimodal Imaging
dc.title18F-FDG PET/CT in Detecting Metastatic Infection in Children.
dc.typeJournal Article
rioxxterms.versionofrecord10.1097/rlu.0000000000001119
rioxxterms.licenseref.startdate2016-04
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfClinical nuclear medicine
pubs.issue4
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging
pubs.publication-statusPublished
pubs.volume41
pubs.embargo.termsNot known
icr.researchteamTranslational Molecular Imagingen_US
dc.contributor.icrauthorOyen, Willemen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record